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Abstract – Development and optimization of novel 
production techniques for drug delivery systems are 
fundamental steps in the “from the bench to the bedside” 
process which is the base of translational medicine. In 
particular, in the current scenery where the need for 
reducing energy consumption, emissions, wastes and risks 
drives the development of sustainable processes, new 
pharmaceutical manufacturing does not constitute an 
exception. In this paper, concepts of process intensification 
are presented and their transposition in drug delivery 
systems production is discussed. Moreover, some examples 
on intensified techniques, for drug microencapsulation and 
granules drying, are reported. 
 
Keywords – process intensification, ultrasonic 
atomization, microwave heating. 
 
I.  INTRODUCTION 
 
The final step of the translational medicine chain is 
the production of medical/pharmaceutical devices 
efficient and widespread for in health maintenance of 
patients. Under the production point of view, current 
approaches in the manufacturing of drug delivery systems 
are focused on the dual goal:  
 to optimize manufacturing processes in response to the 
need for reducing energy consumption, emissions, 
wastes and risks;  
 to innovate the functionality of new formulations using 
biocompatible materials. 
 
Within this frame, several researches were carried out 
in our group (Transport Phenomena and Processes, 
www.minerva.unisa.it) with the aim of bringing the 
engineering point of view on innovation in the 
development of pharmaceutical techniques. Key-word of 
this innovation is “process intensification”: meaning and 
applications are reported in the following.  
 
II.  PROCESS INTENSIFICATION  
 
The current industrial scenery is founded on 
compromises based on the needs of the industrial 
processes developed to satisfy both the increasing market 
requirements and the mandatory rules in sustainable 
productions such as raw material / energy savings, respect 
of environmental constraints of industrial-scale processes 
[1]. In this frame, process intensification represents an 
engineering tool in looking for safer operating conditions, 
lower wastes and costs, higher productivity and 
developing of multifunctional devices [2, 3]. At last this 
new manufacturing vision was defined as an advanced 
strategy which aims to achieve process miniaturization, 
reduction in capital cost, improved inherent safety and 
energy efficiency, and often improved product quality [4]. 
Moreover, benefits of process intensification include 
simpler scale-up procedures, and possibility to allow the 
replacement of batch processing by small continuous 
reactors, which frequently give more efficient overall 
operation [5]. Finally, process intensification contains not 
only the development of novel, miniaturized equipments 
but also intensified methods of processing which may 
involve the use of ultrasonic (US) and radiation energy 
sources such as radio frequencies (RF) and microwaves 
(MW) [4]. Process intensification toolbox is reported in 
Fig. 1. 
 
In this work ultrasonic atomization technique and 
heating treatment assisted by microwave, applied in 
developing of drug delivery systems, are the matter of 
discussion. Both the processes constitute tools for process 
intensification since they involve much less energy with 
respect to conventional techniques commonly adopted in  
atomization of liquid and heating purposes, respectively. 
Moreover, due to their peculiar features that will be 
elucidate in the following sub-sections, uses of US and 
MW can address towards miniaturization of process 
chambers, reducing maintenance costs, and minimize 
denaturation risks due to thermal/mechanical stress of 
sensible materials such as pharmaceuticals [1], [6], [7].  
 
III.  METHODOLOGY 
 
A.  Microencapsulation by ultrasonic atomization  
 
Microencapsulation of drugs is one of the 
manufacturing techniques that guarantees the overcoming 
of serious problems associated to the delivery of drugs 
with poor stability in physiological environments and 
scarcely absorbable. Relevance of encapsulation 
techniques consists in the effectiveness to protect different 
kinds of active molecules (drugs, gene, vitamins and 
proteins) through their envelopment in suitable carriers 
[1]. Microencapsulation can be performed by both 
physical-chemical and mechanical processes [8-10] all 
based on these fundamental steps: incorporation of active 
molecules in opportune bio-compatible carriers; droplets 
formation; solvent removal; microparticles harvest and 
stabilizing treatment [11]. Among the mechanical 
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processes, micro-encapsulation by ultrasonic assisted 
atomization (fine droplets formation) is characterized by 
several interesting features [12]. Briefly, ultrasonic waves 
(ultrasonic frequency allowed: 18-100 kHz) are 
mechanical phenomena that can induce stress in material 
medium by vibrational energy. By ultrasonic atomizer 
very small droplets with uniform size may be formed by 
feeding a fluid, at a controlled rate, through a small orifice 
in the tip of a horn vibrating ultrasonically. Vibration 
energy causes the breakup of liquid in threads and then of 
droplets. In particular, phenomena of cavitation and 
capillary-wave are the two rival hypothesized 
mechanisms to explain fine droplets generation [13].  
 






































Fig. 2.  Energy request for different atomization devices (bars are 
referred to the exercise of conventional atomizers). Working at high 
flow rates (typical condition in plant scale process) ultrasonic assisted 
atomization is confirmed to be a very promising technique in the 
intensification of industrial processes which includes an atomization step 
[13]. 
It is important to note that final dimensions of fine 
droplets are affected from the frequency of the adopted 
ultrasonic waves: an increase in frequency produces more 
fine particles.   
The relevance of the ultrasonic atomization can be 
mainly attributed to its ability to produce drops of small 
size and low inertia since it works involving low 
velocities. This feature allows reducing the energy request 
respect to the more conventional atomization systems 
(nozzle atomizers, two fluid atomizers) (Fig. 2), the 
volume of apparatuses (compact equipment) and the 
mechanical stress of treated feeds avoiding deactivation of 
sensitive substances such as pharmaceuticals [1, 13].  
The role of several operating parameters (solution 
concentration, flow rate, atomization power) in 
atomization process and correlations able to predict the 
features of the droplets as functions of process parameters 
were investigated and reported in [13]. 
 
Starting from aqueous solutions of biocompatible 
polymers, used as drug carriers, microencapsulation 
assisted by ultrasonic atomization was applied to develop 
delivery systems loaded by hydrophilic or lipophilic 
model molecules. In particular, solutions of chitosan or 
alginate loaded respectively with B12 vitamin 
(hydrophilic model molecule) and -tocopherol vitamin 
(TOC, lipophilic model molecule) were used to produce 
microparticles by two different ultrasonic processors 
(VCX 130 PB 130 W, 20 kHz, Sonics & Materials Inc., 
CT, USA; broadband ultrasonic generator mod. 06-
05108- 25 KHz Sono-Tek corporation, NY, USA) and tips 
(sonotrode VC 4020 50 W, 20 kHz, Sonics & Materials 
Inc., CT, USA single channel; dual liquid feed probe 
Sono-Tek 025-00010, Sono-Tek corporation NY, USA) as 
sources of ultrasonic vibration and atomizer, respectively. 
 
Fig.1.  Schematic representation of process intensification concepts [1] 
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Chitosan/B12 feed solution was delivered to the 
single channel sonotrode by a peristaltic pump (Velp 
Scientifica Italia, Usmate, Milan, IT). The produced fine 
drops were collected in the reticulating bulk (sodium 
tripolyphosphate solution, TPP) placed on a magnetic 
stirrer. By crosslinking phenomena between chitosan 
polymeric chains and P3O10
5- ionic groups of 
tripolyphosphate fine rubbery particles were obtained 
(matrix structures of chitosan/B12) (Fig. 3).  
Alginate/TOC (in core channel) and alginate/TOC (in 
core channel) / alginate (in shell channel) feed solutions 
(Fig. 3) were delivered to the double channel sonotrode 
by peristaltic pumps (Verderflex OEM mod. Au EZ, RS 
Components Milan IT, controlled by two systems with 
variable tension Long WEI DC power supply PS305D to 
adjust the delivered solutions flow rate). The produced 
fine drops were collected in the reticulating bulk (calcium 
chloride solution) placed on a magnetic stirrer. By 
crosslinking phenomena between alginate polymeric 
chains and bivalent calcium cations, fine particles with 
matrix and shell - core structures are obtained (Fig. 3).  
All kinds of produced microparticles were separated 
by a filtration process, washed, photographed (by Canon 
digital camera, IXUS 850 IS, by Leica digital camera 
DFC 280 mounted on optical microscope Leica 
Microsystems DM-LP, Wetzlar, D) and subjected to 
diameter measurements by image analysis (using the 
public domain software ImageJ 1.40g, Wayne Rasband, 
National Institutes of Health, USA, freely available at 
http://rsb.info.nih.gov/ij/). Finally, produced particles 
were stabilized by convective drying in oven (ISCO 9000) 
at 45°C or by microwave drying (commercial microwave 
oven De Longhi, mod. Easy max power 700W) until 
reaching constant weight. In Fig. 3 the fundamental steps 
of production were shown. 
 
 
Fig. 3.  Schematic representation of microparticles produced by two 
different sonotrode (single and double channel for matrix and shell core 
structures). 
 
At last, stabilized loaded microparticles were 
subjected to dissolution tests to evaluate the yield of 
encapsulation, and the release kinetics under 
physiological conditions (USP II apparatus, 37°C; 100 
rpm paddle rotating speed; for chitosan particles: buffer 
solution at pH 7.4; for enteric alginate particles: two 
stages protocol in buffer solutions at pH 1 and pH 6.8). 
All the tests were performed in triplicate. 
 
 
B.  Microwave assisted drying 
Interest in applications of microwave power in 
pharmaceuticals treatments (i.e. heating, drying, curing) is 
relatively recent and not well widespread [7]. A non-
consolidated know-how in microwave application for 
pharmaceutical products and, under a more technical 
point of view, the need to have a uniform distribution of 
heat to avoid local overheating of the material, and, 
moreover, the possibility of a temperature uncontrolled 
increase are the main limiting factors [6]. In the last 
twenty years, mainly in Academic researches and in a few 
large-scale plants experiences, microwaves benefits have 
begun to capture attention. In particular, microwaves have 
been: 
 applied in modulating drug and excipient properties via 
specific material microwave interactions [15, 16]; 
 tested in drying operations of powder and granules [17, 
18]; 
 used in single-pot devices to carry out mixing, 
granulation and drying of pharmaceuticals in one vessel 
[17, 19, 20].  
Microwaves are electromagnetic radiation with 
frequency ranging from 300 GHz to 300 MHz; uses of the 
different parts of the spectrum are regulated by 
international agreement. In particular, the frequencies 
0.915 and 2.45 GHz are the most common frequencies 
dedicated to microwave power applications for industrial, 
scientific and medical purposes [21]. Reasons for the 
growing interest of microwave heating can be found in the 
peculiar mechanism for energy transfer: during 
microwave heating, energy is delivered directly to 
materials through molecular interactions with 
electromagnetic field via conversion of electrical field 
energy into thermal energy. This can allow unique 
benefits, such as high efficiency of energy conversion and 
shorter processing times, thus reductions in manufacturing 
costs thanks to energy saving. Moreover, other effects 
have been pointed out, such as the possibility to induce 
new structural properties to irradiated materials 
(development of new materials) and to apply novel 
strategies in chemical syntheses (green techniques) [7]. 
Crucial parameters in microwave heating are the 
dielectric properties of matter; they express the energy 
coupling of a material with electromagnetic microwave 
field and, thus, the heating feasibility [7, 21]. In 
particular, the ability of a material to interact with 
electromagnetic energy is related to the material’s 
complex permittivity (dielectric properties or 
susceptibility). This property is characterized by a 
frequency-depending and is reported as a relative complex 
number: εr =ε/ε0 = ε’-j ε” where ε0 is the vacuum 
permittivity (ε0 = 8.85 10
-12 F/m); ε’ is the part named 
dielectric constant and ε” is the imaginary part known as 
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much energy from an external electric field is stored in 
the material; the loss factor accounts for the loss energy 
dissipative mechanisms in the material. Therefore, a 




Fig. 4. Dielectric constant and loss factor of several excipients with 
different water content (PVP, PolyVinyl-Pyrrolidone; CMC, Carboxy-
Metil-Cellulose) at 2.45 GHz and room condition.  
 
Wet / liquid pharmaceutical dosage forms (hydrogel, 
ointments, syrups) constitute dissipative materials; 
generally, powder pharmaceutical ingredients are poor 
dissipative constituents but when solvents (water, 
alcohols, hydro-alcohol mixtures) are involved in their 
processing, the mixtures permittivity generally increases 
and thus this allows efficacious microwave heating. In 
Fig. 4 dielectric properties at 2.45 GHz of different 
mixtures of water / powder pharmaceutical excipients are 
reported. As one can see, nature of excipients and water 
content determine the microwave heating capability. 
Thus, on the bases of dielectric properties knowledge, 
optimized working protocols must be applied.  
 
Powders of hydroxypropyl methyl cellulose (HPMC, 
a biocompatible polymer used in formulating of hydrogel 
based dosage forms) were used to produce a model 
granular pharmaceutical dosage system dried by 
microwave heating. Water / ethanol mixture (50% v/v) 
was used as wet binder phase in wet granulation process 
carried out in a bench-scale mixer (Mini Mixer MULTI 
LAB Caleva Process Solutions Ltd, UK). Granular product 
was then characterized in terms of size (by image 
analysis, binder phase content (Ohaus moisture balance 
mod MB45), dielectric properties (network analyzer 
Agilent Technologies mod ES 8753 and coaxial probe 
Agilent Technologies mod 85070D). By a multimodal 
microwave cavity (LBP 210/50 Microwave Oven 2300 W, 
InLand, USA) different drying treatments were performed 
to simulate stabilization processes (by reducing the binder 
phase content) allowed in industrial manufacturing to 
guarantee firstly granules inalterability and flowability.  
Drying kinetics was studied to emphasize feasibility 
and advantages of microwave assisted drying in terms of 
reduces process time and thermal stresses in comparison 
to classic convective heating treatments (convective 
granules drying in the conventional oven ISCO 9000; 
temperature measurements were carried out by infrared 
pyrometer Simpson mod. IR-10). All the tests were 
performed in triplicate. 
 
IV.  RESULTS AND DISCUSSION 
 
A. Microencapsulation results 
 
Chitosan/B12 microparticles produced by the single 
channel sonotrode (20 kHz), after convective treatments 
(air bulk temperature: 45°C) showed a spherical 
morphology and an average size of 600 µm. The yield of 
encapsulation (amount of B12 released and 
measured / theoretical loaded amount of B12) was found 
around 12 %. In Fig. 5 the B12 release profile was 
reported.  
 



























Fig. 5. B12 released from chitosan microparticles produced by ultrasonic 
atomization (release medium at pH 7.4).  
 
The release kinetics showed a rapid burst of B12 in 
the aqueous bulk (pH 7.4): in the first 5 min, the released 
B12 was already over 70%; a further increase of 10% was 
monitored in the successive half hour; after 140 min a 
percentage of release of around 90% was achieved. 
These results were attributed mainly to the network 
large mesh-size obtained in reticulation step between TPP 
ionic groups and chitosan chains that allows the fast 
diffusion of B12 from the dried particles to the dissolution 
bulk [22]. 
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Alginate particles, both matrix (only core, without 
protective shell) and shell-core, produced by double 
channel sonotrode (25 kHz), showed a spherical 
morphology an average size of 70 µm. The yield of 
encapsulation (amount of TOC released and 
measured / theoretical loaded amount of TOC) was found 
around 100 %.  
The two kinds of microparticles were stabilized 
adopting both convective (conventional treatment at 45°C 
overnight) and microwave drying (novel treatment, at 
pulsed irradiation in about 30 min) with the aim to 
observe the kinetic rates and possible changes in the 
release properties. The release profiles of both matrix and 
shell-core microparticles (Fig. 6) globally showed that by 
microwave treatments a little delay in TOC release was 
achieved. This demonstrates the microwave drying 
usefulness in the controlled drug release: it can affect, by 
a sort of curing, the polymeric structures.   
 


































Time (min)  







































Fig. 6. -tocopherol released from alginate microparticles (matrix and 
shell-core structures) produced by ultrasonic atomization and stabilized 
by convective drying (up) or by microwave drying (down). 
The enteric test (pH 1 for two hours, to simulate 
gastric conditions, then pH 6.8, i.e. intestine pH) on both 
kinds of microparticles showed different gastroresistance 
properties. In particular, shell-core microparticles have 
assured a better protection of active principle at initial 
stage of pH 1, releasing only the 5% of -tocopherol 
against the 10-20% for matrix particles. Moreover, matrix 
particles have released all the loaded -tocopherol as soon 
as the pH changes from pH 1 to pH 6.8. On the contrary, 
shell-core microparticles were characterized by a delayed 
release.  
 
Summarizing, the combination of two powerful tools 
of process intensification, ultrasonic atomization and 
microwave drying, gives to produced microsystems 
peculiarities (high loading, delayed release) that make 
them of interest for specific drug delivery applications. 
 
 
B. Microwave assisted drying results 
 
Model granules of HPMC/hydro-alcoholic binder 
with a wet phase (or briefly moisture) content around 31% 
(wb, wet bases) were subjected to both convective and 
microwave drying treatments. To this aim given amounts 
of granules were placed in a Petri dish and undergone to 
weight and temperature measurements after different 
process times. To compare all the drying curves (moisture 
vs time) residual moisture was expressed as moisture 













        
 
where M(t), Me and M0 are the actual, the equilibrium 
and the initial moisture, respectively.  
 
In Fig. 7 were reported the drying curves obtained by 
microwave assisted heating at different power (115 W; 
575 W and 920 W). It is possible to note that the 
stabilization process (completed when the granules wet 
phase was reduced at 2-3% wb) occurred in 15-30 min 
depending on the applied power intensity (920 W- 
115 W). “Variable power” label referred to a controlled 
power protocol developed to irradiate, at maximum power 
intensity, granules with high moisture content and at 
lowest power intensity, almost dried granules. By this 
way granules temperature was kept at low values avoiding 
thermal stresses; sudden increases were observed only at 
the end of drying treatments (Fig. 8).  
It is important to note that microwave apparatus was 
not interested by heating phenomena because heat was 
directly generated in wet HPMC granules by dissipative 
mechanisms due to the dielectric properties of the hydro-
alcoholic binder phase (dielectric properties: wet granules 
ε =3,24 - j 1,07; dried granules ε =1,90 - j 0,17).  
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Fig. 7. Drying curves of HPMC granules referred to microwave 
treatments at 2.45 GHz at different power.  
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Fig. 8. Temperature profiles as function of residual moisture ratio.  
 
In Fig. 9 were reported the drying curves obtained by 
convective treatments at different temperature of air bulk 
(60°C; 90°C and 105°C). Stabilization process occurred 
in 30 - 120 min depending on the air bulk temperature 
(105 - 60°C); globally, granules were exposed to high 
temperature for prolonged time (Fig. 10).  
 
Dried model granules, treated both via convective 
methods and through microwave processes, showed a 
roughly spherical morphology and an average size of 
1,55 mm, features very close to the values of the wet 
granules. Moreover their final flowability was found good 
(dried granules Carr’s index  17%; HPMC powders 
Carr’s index  33%, where a Carr’s index until 20% 
denotes good material flowability).  
  
Summarizing, the relevance of the microwave 
treatments was highlighted by the shorter process time 
and by e availability of an ad hoc process parameter 




Fig. 9. Drying curves of HPMC granules referred to convective 
treatments at different bulk temperatures.  
 

































Fig. 10. Temperature profiles as function of residual moisture ratio.  
 
 
V.  CONCLUSIONS 
 
Translational medicine is based on a multidisciplinary 
approach for the conversion of basic science findings into 
novel therapies. Indeed, the engineering point of view 
could be useful in defining novel preparation techniques 
for drug delivery systems. 
 
In this work, two different applications of ultrasonic 
and microwave energy were presented (part A and part 
B).  
In the part A, the production and the characterization 
of three kinds of microparticles produced by ultrasonic 
atomization were reported. Both chitosan and alginate 
polymer solutions were successfully atomized producing 
microparticles loaded with different active molecules.  
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In the part B, comparison between the drying kinetics 
of wet HPMC granules carried out by convective and 
microwave treatments was performed highlighting that 
microwave heating requires shorter process time and on 
the bases of material dielectric properties, gives the 
availability of an ad hoc process parameter (power 
intensity) to be tuned to minimize possible thermal 
damage.  
Both the applications are of great technological 
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